Abstract
A 71-year-old man in reasonable fitness was diagnosed with poorly differentiated prostate adenocarcinoma with extensive bony metastases in 2000. He had a prostate specific antigen (PSA) concentration of greater than 900 ng/mL and was prescribed treatment with luteinising-hormone-releasing-hormone antagonist therapy in the form of goserelin injections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
